These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12452361)

  • 21. Competition Commission recommendations: plans for implementation.
    Vet Rec; 2005 Sep; 157(11):302-3. PubMed ID: 16155233
    [No Abstract]   [Full Text] [Related]  

  • 22. Privilege to dispense.
    Wray JG
    Vet Rec; 2001 Feb; 148(6):186. PubMed ID: 11258727
    [No Abstract]   [Full Text] [Related]  

  • 23. RCVS disciplinary hearings.
    Bailey J
    Vet Rec; 2002 Sep; 151(12):363; author reply 363. PubMed ID: 12371697
    [No Abstract]   [Full Text] [Related]  

  • 24. Supply of POMs.
    Sainz-Pardo L
    Vet Rec; 2003 Jul; 153(3):96. PubMed ID: 12892274
    [No Abstract]   [Full Text] [Related]  

  • 25. Competition in drug sales.
    Whitford RE
    J Am Vet Med Assoc; 2013 Aug; 243(3):324. PubMed ID: 23865870
    [No Abstract]   [Full Text] [Related]  

  • 26. Draft legislation on supply of POMs: how will it affect you?
    J Small Anim Pract; 2005 Apr; 46(4):207. PubMed ID: 15835242
    [No Abstract]   [Full Text] [Related]  

  • 27. RCVS disciplinary hearings.
    Ostle GN
    Vet Rec; 2002 Sep; 151(12):363-4; author reply 364. PubMed ID: 12371696
    [No Abstract]   [Full Text] [Related]  

  • 28. RCVS to pursue concerns over the Competition Commission's recommendations on POMS.
    Vet Rec; 2003 Jun; 152(24):732-3. PubMed ID: 12833932
    [No Abstract]   [Full Text] [Related]  

  • 29. Competition Commission inquiry into the supply of POMs.
    Jinman PC
    Vet Rec; 2002 Jun; 150(23):732. PubMed ID: 12081310
    [No Abstract]   [Full Text] [Related]  

  • 30. DTI consults on legislation to improve competition in the POMs market.
    Vet Rec; 2005 Feb; 156(9):262-3. PubMed ID: 15765892
    [No Abstract]   [Full Text] [Related]  

  • 31. [Does the veterinarian continue to sell drugs?].
    van Heuven-van Kats K
    Tijdschr Diergeneeskd; 2011 Apr; 136(4):279. PubMed ID: 21534285
    [No Abstract]   [Full Text] [Related]  

  • 32. Competition Commission's investigation into POMs.
    Wray JG
    Vet Rec; 2002 Apr; 150(17):554. PubMed ID: 12019539
    [No Abstract]   [Full Text] [Related]  

  • 33. Veterinary practice expenses and financial ratios, 2005.
    Shepherd AJ
    J Am Vet Med Assoc; 2008 Apr; 232(7):998-9. PubMed ID: 18380614
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rate of exchange variation of Swiss francs to euros: effects on veterinary products in Switzerland].
    Schweiz Arch Tierheilkd; 2015 Mar; 157(3):120, 136. PubMed ID: 26753323
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of the loss of drug sales for practitioners.
    Whitford RE
    J Am Vet Med Assoc; 2011 Jul; 239(2):181. PubMed ID: 21756170
    [No Abstract]   [Full Text] [Related]  

  • 36. Veterinary pharmaceuticals--an endangered species?
    Vet Rec; 2001 Oct; 149(17):508. PubMed ID: 11708634
    [No Abstract]   [Full Text] [Related]  

  • 37. Competition Commission identifies issues for further consideration.
    Vet Rec; 2002 Apr; 150(16):494-6. PubMed ID: 12017523
    [No Abstract]   [Full Text] [Related]  

  • 38. [It is about more than the price of drugs!].
    Trolliet C
    Schweiz Arch Tierheilkd; 2012 Mar; 154(3):103. PubMed ID: 22536598
    [No Abstract]   [Full Text] [Related]  

  • 39. Modest cost of veterinary services and goods to farmers in Canada.
    Canadian Animal Health Institute
    Can Vet J; 2015 Jul; 56(7):700. PubMed ID: 26130830
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment on: veterinarians' profit on drug dispensing.
    Grave K; Wegener HC
    Prev Vet Med; 2006 Dec; 77(3-4):306-8. PubMed ID: 16527367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.